Studying immunity to COVID-19

What is the COVID PROFILE study?

There is still a lot we don’t know about COVID-19.

  • What makes a person more susceptible to contracting COVID-19?
  • Why do some people develop severe illness while others remain relatively well?
  • How long does immunity last after having COVID-19 or being vaccinated?

The COVID PROFILE study aims to find answers to these and other important questions by comparing immune responses in people who have experienced coronavirus infection, or who have been vaccinated, to people who have not.

These insights will help us better understand the factors that make a person susceptible to COVID-19 and the severity of the illness they might develop.

This will help doctors ensure those most at risk receive appropriate medical care, and will help inform vaccine design and public health measures in the future.

Enrolment for this study has now closed.

For more information see the COVID PROFILE FAQs.


The Australian First Few X (FFX) research study for COVID-19

The Australian First Few X (FFX) study aims to understand how emerging COVID-19 variants are transmitted within households and families.

The study will also provide information about:

  • changes in disease symptoms over time
  • impacts of different variants
  • Impacts of different vaccines
  • long-term effects on immunity against COVID-19

We are seeking participants from households where:

  • One or more residents has tested positive to COVID-19 within the past seven days
  • All residents are aged 18 years or over
  • All residents agree to participate

If you (and your household members) agree to participate, you will:

  • provide initial information about you, your household and your experience with COVID-19
  • complete a daily symptom diary for up to 28 days which will take 2–5 minutes each day
  • have at least one COVID-19 PCR swab test (to enable genomic study of the virus)
  • provide blood samples – two in the first 28 days, and then further samples up to a year after your infection (to enable study of your immune response)
  • be involved in 30–60 minutes of follow-up interviews in the initial period of the study

The FFX study, or ‘First Few X’ (where ‘X’ represents the first identified cases of COVID-19), is designed to help gain an understanding of the infectiousness and severity of COVID-19 in Australia. The Australian FFX study is coordinated through the Australian Department of Health, and is based on a World Health Organization protocol. It is one of many similar studies being conducted worldwide.

How to participate

  • If everyone in your household is an adult (aged 18 years or over), please register your interest here
  • If your household includes any children (under the age of 18), please contact the Murdoch Children’s Research Institute (MCRI) by email – ffx28@mcri.edu.au
  • Visit the APPRISE website to find out more about the Australian First Few X study

Responding to COVID-19

WEHI is leading a number of major research responses to COVID-19 in collaboration with research partners in universities, hospitals and the private sector.

Our researchers are working towards better approaches to diagnose, treat and prevent the spread of coronaviruses, both to address the current COVID-19 pandemic, as well as in preparedness for future coronaviral disease outbreaks.

Find out more about WEHI’s COVID-19 response.

Media enquiries

Sign up to our quarterly newsletter Illuminate

Find out about recent discoveries, community supporters and more.

Illuminate Winter 2024
View the current issue